Pacific Biosciences of California, Inc.
$1.35
The Read: Pacific Biosciences historically experiences severe stock moves around 23%, driven by disappointing forward guidance, revenue misses, and investor concerns over dilution and sequencing demand, with moves ranging from mild 0.
Price
Overlays
Panel
PACB
Hover to view data
No Data